Advisor Group Holdings, Inc. Cara Therapeutics, Inc. Transaction History

Advisor Group Holdings, Inc.

  • $42.2 Billion
  • Q3 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Cara Therapeutics, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 9,458 shares of CARA stock, worth $48,897. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,458
Previous 10,769 12.17%
Holding current value
$48,897
Previous $2,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$0.26 - $0.38 $340 - $498
-1,311 Reduced 12.17%
9,458 $2,000
Q2 2024

Aug 13, 2024
SELL
$0.24 - $0.92 $426 - $1,633
-1,776 Reduced 14.16%
10,769 $2,000
Q1 2024

May 10, 2024
BUY
$0.52 - $1.05 $2,198 - $4,439
4,228 Added 50.84%
12,545 $11,000
Q4 2023

Feb 12, 2024
SELL
$0.6 - $1.65 $17,241 - $47,412
-28,735 Reduced 77.55%
8,317 $6,000
Q3 2023

Nov 13, 2023
BUY
$1.67 - $3.33 $2,339 - $4,665
1,401 Added 3.93%
37,052 $62,000
Q2 2023

Aug 10, 2023
BUY
$2.83 - $4.94 $860 - $1,501
304 Added 0.86%
35,651 $100,000
Q1 2023

May 12, 2023
SELL
$4.89 - $12.27 $3,662 - $9,190
-749 Reduced 2.08%
35,347 $173,000
Q4 2022

Feb 10, 2023
BUY
$8.88 - $12.77 $272,660 - $392,102
30,705 Added 569.56%
36,096 $387,000
Q3 2022

Nov 14, 2022
SELL
$8.24 - $12.56 $1,705 - $2,599
-207 Reduced 3.7%
5,391 $52,000
Q2 2022

Aug 10, 2022
SELL
$7.45 - $13.84 $5,706 - $10,601
-766 Reduced 12.04%
5,598 $51,000
Q1 2022

May 04, 2022
BUY
$9.94 - $12.65 $2,504 - $3,187
252 Added 4.12%
6,364 $1.71 Million
Q3 2021

Nov 05, 2021
BUY
$11.55 - $16.06 $8,616 - $11,980
746 Added 13.9%
6,112 $94,000
Q2 2021

Aug 02, 2021
SELL
$12.38 - $29.19 $25,007 - $58,963
-2,020 Reduced 27.35%
5,366 $76,000
Q1 2021

May 13, 2021
SELL
$15.07 - $21.71 $12,960 - $18,670
-860 Reduced 10.43%
7,386 $160,000
Q4 2020

Feb 10, 2021
SELL
$12.72 - $16.16 $5,011 - $6,367
-394 Reduced 4.56%
8,246 $126,000
Q3 2020

Nov 12, 2020
SELL
$12.34 - $17.92 $55,616 - $80,765
-4,507 Reduced 34.28%
8,640 $110,000
Q2 2020

Aug 14, 2020
SELL
$12.39 - $17.33 $32,164 - $44,988
-2,596 Reduced 16.49%
13,147 $225,000
Q1 2020

May 18, 2020
BUY
$9.12 - $17.78 $143,576 - $279,910
15,743 New
15,743 $207,000

Others Institutions Holding CARA

# of Institutions
74
Shares Held
12.8M
Call Options Held
0
Put Options Held
0
View Full List

About Cara Therapeutics, Inc.

CARA Quotes by TradingView
  • Ticker CARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,725,900
  • Market Cap $278M
  • Description
  • Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...
More about CARA
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email